The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
NOMINATOR: Feasibility of genomic testing of rare cancers to match cancer to treatment.
 
Damien Kee
No Relationships to Disclose
 
Olga Kondrashova
No Relationships to Disclose
 
Sumitra Ananda
No Relationships to Disclose
 
Michael Paul Brown
Honoraria - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst)
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Cartherics; GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pharmaust (Inst); Roche (Inst); Zucero Therapeutics (Inst)
 
Paul Andrew Cohen
No Relationships to Disclose
 
Andrew Dean
No Relationships to Disclose
 
Jayesh Desai
Consulting or Advisory Role - Amgen (Inst); BeiGene; Biocon; Eisai; Lilly
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
 
Andrew Fellowes
No Relationships to Disclose
 
Stephen B. Fox
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Roche
Expert Testimony - AstraZeneca; MSD
Travel, Accommodations, Expenses - AstraZeneca; MSD; Ventana Medical Systems
 
Alison Hadley
No Relationships to Disclose
 
Dianne Lindsay
No Relationships to Disclose
 
Linda R. Mileshkin
No Relationships to Disclose
 
Kenneth John O'Byrne
Stock and Other Ownership Interests - CARP Pharmaceuticals
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer/EMD Serono; Roche; Teva
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Natera; Novartis; Pfizer; Roche/Genentech; Teva
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Janssen-Cilag; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - I am named on 4 patents/provisional patents held by the University of Queensland (Inst)
Travel, Accommodations, Expenses - boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Owen W.J. Prall
No Relationships to Disclose
 
Hamish Scott
No Relationships to Disclose
 
David Morgan Thomas
No Relationships to Disclose
 
Richard Vines
No Relationships to Disclose
 
Nic Waddell
Research Funding - Cooperative Research Centres (Inst)
Patents, Royalties, Other Intellectual Property - GenomiQa (Inst)
 
Anthony Papenfuss
No Relationships to Disclose
 
Clare L. Scott
Research Funding - Clovis Oncology; Eisai; Roche/Genentech; Sierra Oncology
Patents, Royalties, Other Intellectual Property - Royalty agreement for venetoclax (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca
Other Relationship - Clovis Oncology